XERS vs HROW
Comparison between Xeris Biopharma Holdings Inc (XERS, Company) and Harrow Inc (HROW, Company).
Both XERS and HROW are from the Healthcare sector.
5-Year PerformanceHROW has outperformed XERS, delivering a return of +33.9% compared to +29.1%
XERS vs HROW - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
XERS vs HROW - Historical Returns
Returns include dividend reinvestment.
XERS vs HROW - Annual Returns (2007 - 2026)
Returns include dividend reinvestment.
| Year | XERS | HROW |
|---|---|---|
| 2026 | +13.33% | -22.12% |
| 2025 | +126.88% | +34.03% |
| 2024 | +49.67% | +180.75% |
| 2023 | +109.82% | -24.22% |
| 2022 | -52.67% | +70.44% |
| 2021 | -44.82% | +17.55% |
| 2020 | -26.57% | -6.03% |
| 2019 | -59.71% | +51.07% |
| 2018 | -15.92% | +228.90% |
| 2017 | N/A | -31.17% |
| 2016 | N/A | -63.24% |
| 2015 | N/A | -8.09% |
| 2014 | N/A | +107.76% |
| 2013 | N/A | -61.60% |
| 2012 | N/A | +204.69% |
| 2011 | N/A | -84.81% |
| 2010 | N/A | -45.52% |
| 2009 | N/A | +50.00% |
| 2008 | N/A | -63.64% |
| 2007 | N/A | -8.33% |
XERS vs HROW Drawdown Comparison
The maximum drawdown for XERS was -96.22%, occurring on Jan 5, 2023. This drawdown has not yet recovered.
The maximum drawdown for HROW was -99.46%, occurring on Mar 19, 2012. This drawdown has not yet recovered.
The current XERS drawdown is -69.41%. The current HROW drawdown is -71.83%.
| Rank | XERS | HROW |
|---|---|---|
| #1 | -96.22% Sep 10, 2018 - Jan 5, 2023 | -99.46% Oct 4, 2007 - Mar 19, 2012 |
| #2 | -17.12% Jul 24, 2018 - Aug 14, 2018 | N/A |
| #3 | -10.98% Jun 21, 2018 - Jul 20, 2018 | N/A |
| #4 | -7.87% Aug 14, 2018 - Aug 22, 2018 | N/A |
| #5 | -3.41% Aug 23, 2018 - Sep 7, 2018 | N/A |
| #6 | -3.07% Jul 20, 2018 - Jul 24, 2018 | N/A |
Correlation
Correlation between XERS and HROW is -0.14 which considered as a very weak or no correlation - the stocks move independently of each other.
Select Stocks to Compare
More Comparisons
Compare with similar stocks